molecules 2

We are rapidly working on multiple, in vivo drug discovery programs

We accelerate personalized drug discovery through rapid in vivo drug repurposing. Once we have determined that the cause of the disease is genetic and validated that the causative gene is present in the worms and fishes genomes, our programs enter into three key steps.

RAPIDLY ADVANCING PROGRAMS

*The ALS Project has been pursued academically by the University of Montreal and the University of Calgary.

INFORMATION FOR FAMILIES

Modelis is patient-centric, and we will guide you each step of the way. 

©2020 Modelis inc. All rights reserved